The Pharmaceutical Journal
Vol 276 No 7403 p646
3 June 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Chlamydia screening value

Benefits of chlamydia screening programmes might have been overestimated, say researchers who analysed data from 43,715 women in Uppsala, Sweden (Sexually Transmitted Infections 2006;82:212). They found a lower-than-expected incidence of chlamydia-associated complications by the age of 35 years (up to 4 per cent overall and up to 7 per cent in those with a previous chlamydia infection).